Trials / Sponsors / Reneo Pharma Ltd
Reneo Pharma Ltd
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | An Open Label, Long Term Safety Study of REN001 in Primary Mitochondrial Myopathy Patients (Stride Ahead) Primary Mitochondrial Myopathy | Phase 2 / Phase 3 | 2022-02-01 |
| Completed | An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy P Primary Mitochondrial Myopathy | Phase 2 | 2021-05-21 |
| Completed | A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Diso Fatty Acid Oxidation Disorder | — | 2021-01-15 |
| Completed | A Study of the Safety of REN001 in Patients With McArdle Disease McArdle Disease | Phase 1 | 2019-12-10 |
| Terminated | A Study of the Safety of REN001 in Patients With Primary Mitochondrial Myopathy Primary Mitochondrial Myopathy | Phase 1 | 2019-05-10 |
| Completed | A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders Fatty Acid Oxidation Disorders | Phase 1 | 2019-04-04 |